0001144204-18-035421.txt : 20180622
0001144204-18-035421.hdr.sgml : 20180622
20180622170318
ACCESSION NUMBER: 0001144204-18-035421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180620
FILED AS OF DATE: 20180622
DATE AS OF CHANGE: 20180622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SANTINI GINO
CENTRAL INDEX KEY: 0001276038
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 18915197
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: New York
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031113
4
1
tv496988_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-06-20
0
0001270073
INTERCEPT PHARMACEUTICALS, INC.
ICPT
0001276038
SANTINI GINO
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK
NY
10001
1
0
0
0
Common Stock
2018-06-20
4
A
0
1787
0
A
5714
D
Option to Purchase Common Stock
85.12
2018-06-20
4
A
0
2748
0
A
2028-06-20
Common Stock
2748
2748
D
Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2019 Annual Meeting of Stockholders.
All of the shares subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2019 Annual Meeting of Stockholders.
/s/ Mark Pruzanski, as attorney-in-fact
2018-06-22